IDTF-accredited end-to-end ambulatory ECG monitoring service pairing certified review with direct-to-CMS billing support.
iRhythm Technologies, a San Francisco-based company, develops and distributes cardiac rhythm monitoring devices.
Founded in San Francisco, iRhythm Technologies focuses on developing and distributing advanced cardiac rhythm monitoring devices. Their core mission is to redefine the way cardiac arrhythmias are diagnosed, enhancing patient care through innovative technology. The company’s flagship product, the Zio monitor, is designed for patient comfort with features like waterproof housing and high breathability. iRhythm serves a diverse market including physicians, clinical staff, and patients across the United States.nniRhythm Technologies has analyzed over a billion hours of heartbeat data and published numerous peer-reviewed studies, underscoring their impact in the medical field.
Notable investors and affiliated individuals include prominent venture capital firms and experienced healthcare professionals. The company's achievements in patient compliance and data accuracy have significantly advanced cardiac care, making them a leader in the industry.

Implicity
implicity.com

RhythmScience

AliveCor
alivecor.com

Innerpulse

Atrility Medical
atrility.com
Impedance Cardiology Systems

Rhythm Management Group
myrhythmnow.com

Masimo
masimo.com

Cercacor Laboratories
cercacor.com

Cardiac Insight

Cardiox
cardiox.com

Octagos Health
octagoshealth.com

Qardio
qardio.com

ReThink Medical

Oracle Health
Companies similar to iRhythm include Implicity, RhythmScience, AliveCor and Innerpulse.
iRhythm was founded in 2006.
iRhythm's headquarters is located in San Francisco, CA, US.
iRhythm's most recent funding round was for $220M (USD) in August 2020.
As of Aug 21, 2020, iRhythm has disclosed funding of $533.2M (USD). Undisclosed round amounts are excluded.
iRhythm has 1,793 employees as of Feb 6, 2024.